MPT · Medical Properties Trust Inc

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2026.

Shares will be earned based on the achievement of specific performance thresholds pertaining to the Company's reduction of overall debt and cash revenue growth, as defined and set by our compensation committee, over the period from January 1, 2026 through December 31, 2028, with the opportunity to earn up to one third of the award for 2026 performance against the specified measures. The actual number of shares to be issued will vary depending upon the achievement of these specific performance thresholds.

Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2026.

Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2026.

Shares will be earned based on the achievement of specific performance thresholds pertaining to the Company's reduction of overall debt and cash revenue growth, as defined and set by our compensation committee, over the period from January 1, 2026 through December 31, 2028, with the opportunity to earn up to one third of the award for 2026 performance against the specified measures. The actual number of shares to be issued will vary depending upon the achievement of these specific performance thresholds.

Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2026.

Shares will be earned based on the achievement of specific performance thresholds pertaining to the Company's reduction of overall debt and cash revenue growth, as defined and set by our compensation committee, over the period from January 1, 2026 through December 31, 2028, with the opportunity to earn up to one third of the award for 2026 performance against the specified measures. The actual number of shares to be issued will vary depending upon the achievement of these specific performance thresholds.

Shares will be earned based on the achievement of specific performance thresholds pertaining to the Company's reduction of overall debt and cash revenue growth, as defined and set by our compensation committee, over the period from January 1, 2026 through December 31, 2028, with the opportunity to earn up to one third of the award for 2026 performance against the specified measures. The actual number of shares to be issued will vary depending upon the achievement of these specific performance thresholds.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2026.

Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2026.

Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2026.

Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2026.

Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2026.

Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2026.

Shares will be earned based on the achievement of specific performance thresholds pertaining to the Company's reduction of overall debt and cash revenue growth, as defined and set by our compensation committee, over the period from January 1, 2026 through December 31, 2028, with the opportunity to earn up to one third of the award for 2026 performance against the specified measures. The actual number of shares to be issued will vary depending upon the achievement of these specific performance thresholds and further adjusted pursuant to modifier provisions in the award that are based on the Company's total return to shareholders.

The total amount of securities beneficially owned following the reported transaction includes a reduction of shares that were forfeited due to only partially satisfying the performance thresholds established as part of the 2023 Performance Share Award.

Shares will be earned based on the achievement of specific performance thresholds pertaining to the Company's reduction of overall debt and cash revenue growth, as defined and set by our compensation committee, over the period from January 1, 2026 through December 31, 2028, with the opportunity to earn up to one third of the award for 2026 performance against the specified measures. The actual number of shares to be issued will vary depending upon the achievement of these specific performance thresholds and further adjusted pursuant to modifier provisions in the award that are based on the Company's total return to shareholders.

The total amount of securities beneficially owned following the reported transaction includes a reduction of shares that were forfeited due to only partially satisfying the performance thresholds established as part of the 2023 Performance Share Award.

Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2026.

Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2026.

Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2026.

This transaction was executed in multiple trades at prices ranging from $4.99 to $5.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Represents a gift of shares of common stock to a charitable organization for a planned contribution that was pledged several years ago.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

Shares vest at the beginning of each calendar quarter ending March 31, 2028.

The shares were granted under the Medical Properties Trust, Inc. ("the Company") Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified Company total shareholder return ("TSR") hurdles during the three-year period ending April 14, 2028 as follows: (i) if the Company's TSR reaches 20%, 100% of the shares will be earned; (ii) if the Company's TSR reaches 40%, 200% of the shares will be earned; and (iii) if the Company's TSR reaches 60%, 300% of the shares will be earned. The actual number of shares to be earned will be determined based on the trailing 20-trading day average, determined quarterly; provided, however, following the end of such three-year performance period, achievement of performance between specific TSR hurdles described above will be determined using straight line linear interpolation (continued on footnote 3).

Earned shares will become vested in equal quarterly installments over one year following the date the shares are earned, provided that all unvested earned shares will vest in full on the date that the Compensation Committee makes the final determination regarding performance metrics following the end of the three-year performance period, subject to the grantee's continued employment through such date.

The shares were granted under the Medical Properties Trust, Inc. ("the Company") Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified Company total shareholder return ("TSR") hurdles during the three-year period ending April 14, 2028 as follows: (i) if the Company's TSR reaches 20%, 100% of the shares will be earned; (ii) if the Company's TSR reaches 40%, 200% of the shares will be earned; and (iii) if the Company's TSR reaches 60%, 300% of the shares will be earned. The actual number of shares to be earned will be determined based on the trailing 20-trading day average, determined quarterly; provided, however, following the end of such three-year performance period, achievement of performance between specific TSR hurdles described above will be determined using straight line linear interpolation (continued on footnote 3).

Earned shares will become vested in equal quarterly installments over one year following the date the shares are earned, provided that all unvested earned shares will vest in full on the date that the Compensation Committee makes the final determination regarding performance metrics following the end of the three-year performance period, subject to the grantee's continued employment through such date.

The shares were granted under the Medical Properties Trust, Inc. ("the Company") Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified Company total shareholder return ("TSR") hurdles during the three-year period ending April 14, 2028 as follows: (i) if the Company's TSR reaches 20%, 100% of the shares will be earned; (ii) if the Company's TSR reaches 40%, 200% of the shares will be earned; and (iii) if the Company's TSR reaches 60%, 300% of the shares will be earned. The actual number of shares to be earned will be determined based on the trailing 20-trading day average, determined quarterly; provided, however, following the end of such three-year performance period, achievement of performance between specific TSR hurdles described above will be determined using straight line linear interpolation (continued on footnote 3).

Earned shares will become vested in equal quarterly installments over one year following the date the shares are earned, provided that all unvested earned shares will vest in full on the date that the Compensation Committee makes the final determination regarding performance metrics following the end of the three-year performance period, subject to the grantee's continued employment through such date.